Brain atrophy: hippocampal asymmetry

Quibim

Quibim’s Hippocampal atrophy & asymmetry quantifies the volumes of the right and left hippocampus to help assess hippocampal atrophy (HA) and asymmetry early. The suite may be used to aid diagnosis and monitoring of patients by characterizing subtle alterations in hippocampal physiology and morphology that are associated with temporal lobe epilepsy (TLE).

Product specifications

Information source: Vendor
Last updated: Feb. 11, 2022

General
Product name	Brain atrophy: hippocampal asymmetry
Company	Quibim
Subspeciality	Neuro
Modality	MR
Disease targeted	Temporal lobe epilepsy (TLE)
Key-features	Main region volume and total volume
Suggested use	Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population	Patients associated with Temporal lobe epilepsy (TLE)
Input	MRI T1 GRE 3D T1 Fast Gradient Echo
Input format
Output	One-page structured report: 3D hippocampus render, hippocampus segmentation, table with volume statistics, normative graphs of volume and asymmetry
Output format	DICOM Secondary Capture / PDF
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	Automatically, right after the image acquisition
Processing time	> 10 minutes
Certification
CE	Certified, Class IIa , MDD
FDA	No or not yet
Market presence
On market since	01-2019
Distribution channels	Alma HEALTH PLATFORM
Countries present (clinical, non-research use)	6
Paying clinical customers (institutes)	5+
Research/test users (institutes)
Pricing
Pricing model	License
Based on	Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers